Reduction in oxidative stress levels, inhibition of cell proliferation, and induction of cell apoptosis in cervical, pancreatic, liver, lung, and ovarian cancers [145]Promotion of the expression of several cytoprotective genes (such as catalase, glutathione S-transferase, and superoxide dismutase) through the epigenetic reactivation of the Nrf2 pathway [147]Cell protection from ultraviolet-associated tumorigenesis [165]. The gene discussed is NFE2L2; the disease is ovarian carcinoma.